Patent ID: 7417022

Claim:
A pharmacological composition comprising: (A) parathyroid hormone; and (B) at least one carrier compound having the formula 2-HO—Ar—CONR 8 —R 7 —COOH wherein Ar is a substituted or unsubstituted phenyl or naphthyl; R 7 is selected from the group consisting of C 4 to C 20 alkyl, C 4 to C 20 alkenyl, phenyl, naphthyl, (C 1 to C 10 alkyl) phenyl, (C 1 to C 10 alkenyl)phenyl, (C 1 to C 10 alkyl) naphthyl, (C 1 to C 10 alkenyl)naphthyl, phenyl (C 1 to C 10 alkyl), phenyl (C 1 to C 10 alkenyl), naphthyl (C 1 to C 10 alkyl), and naphthyl (C 1 to C 10 alkenyl); R 8 is selected from the group consisting of hydrogen, C 1 to C 4 alkyl, C 1 to C 4 alkenyl, hydroxy, and C 1 to C 4 alkoxy; R 7 is optionally substituted with C 1 to C 4 alkyl, C 1 to C 4 alkenyl, C 1 to C 4 alkoxy, —OH, —SH and —CO 2 R 9 any combination thereof; R 9 is hydrogen, C 1 to C 4 alkyl or C 1 to C 4 alkenyl; R 7 is optionally interrupted by oxygen, nitrogen, sulfur or any combination thereof; with the proviso that the compounds are not substituted with an amino group in the position alpha to the acid group; or salts thereof.